Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention

類似資料

• Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention.
  著者:: Jinghan Jenny Chen, 等
  出版事項: (2015-01-01)
• 72 Use of Palivizumab in Canada; Data from the CARESS registry 2005–2017
  著者:: Mitchell, Ian, 等
  出版事項: (2019)
• 73 Changes in Palivizumab usage in Canada 2005–2017 (Data from CARESS registry)
  著者:: Mitchell, Ian, 等
  出版事項: (2019)
• A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
  著者:: Paes, B., 等
  出版事項: (2012)
• Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries
  著者:: Paes, Bosco, 等
  出版事項: (2013)